LifeVantage Corporation (NASDAQ: $LFVN) reported 3QFY26 results below expectations as continued declines in the MindBody GLP-1 customer cohort pressured active accounts and revenue growth. 🔹 Active accounts declined to 109k as competition from pharmaceutical GLP-1 alternatives continued to weigh on the MindBody customer base 🔹 Incoming CEO Terrence Moorehead joins in August, bringing more than 25 years of direct selling and consumer products leadership experience 🔹 Management highlighted the new VIP bonus program and an upcoming science-backed “hero product” launch as potential catalysts for renewed growth momentum Check out Douglas M. Lane, CFA's full report for more! $LFVN #HealthAndWellness# #Nutrigenomics# #ConsumerHealth# #Supplements# #DirectSelling# #NASDAQ# #SmallCap# #Stocks# #Investing# #Wellness# #WaterTowerResearch# @lifevantage